cyt-500
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Glutamate carboxypeptidase IIBINDING AGENT
FOLH1 binding agent
- Glutamate carboxypeptidase IIImmunity, passive
FOLH1 immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 177-Lu
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109676 ↗
- ChEMBLCHEMBL2109553 ↗
Also known as
- cyt-500
- cyt-500 (177lu)